Overall grade IV toxicity and NRM
. | Nonablative patients, % (n = 60) . | Ablative patients, % (n = 74) . | OR or HR*(95% CI) . | Adjusted†OR or HR (95% CI) . | P‡ . |
---|---|---|---|---|---|
Overall grade IV toxicity | 32 | 69 | 4.8 (2.3-10) | 9.4 (2.7-32) | .0001 |
Day 100 NRM | 12 | 18 | 1.4 (0.5-3.4) | 3.6 (0.9-16) | .07 |
1-y NRM | 20 | 32 | 1.4 (0.7-2.8) | 3.0 (1.0-8.7) | .04 |
. | Nonablative patients, % (n = 60) . | Ablative patients, % (n = 74) . | OR or HR*(95% CI) . | Adjusted†OR or HR (95% CI) . | P‡ . |
---|---|---|---|---|---|
Overall grade IV toxicity | 32 | 69 | 4.8 (2.3-10) | 9.4 (2.7-32) | .0001 |
Day 100 NRM | 12 | 18 | 1.4 (0.5-3.4) | 3.6 (0.9-16) | .07 |
1-y NRM | 20 | 32 | 1.4 (0.7-2.8) | 3.0 (1.0-8.7) | .04 |